{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:36:28Z","timestamp":1790116588632,"version":"4.0.1"},"reference-count":157,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.micpath.2022.105622","type":"journal-article","created":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T12:57:17Z","timestamp":1654606637000},"page":"105622","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["HTLV, a multi organ oncovirus"],"prefix":"10.1016","volume":"169","author":[{"given":"Samaneh","family":"Ramezani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6814-5992","authenticated-orcid":false,"given":"Seyed Abdolrahim","family":"Rezaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Farjami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neshat","family":"Ebrahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasaneen Kudhair","family":"Abdullabass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Ismael","family":"Ibrahim Jebur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houshang","family":"Rafatpanah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Mehdi","family":"Akbarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2022.105622_bib1","doi-asserted-by":"crossref","first-page":"5926","DOI":"10.1038\/sj.onc.1208980","article-title":"History of the discoveries of the first human retroviruses: HTLV-1 and HTLV-2","author":"Gallo","year":"2005","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.micpath.2022.105622_bib2","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1080\/15389588.2010.535227","article-title":"Determinants of seat belt use among drivers in Sabzevar, Iran: a comparison of theory of planned behavior and health belief model","volume":"12","author":"Ali","year":"2011","journal-title":"Traffic Inj. Prev."},{"issue":"9","key":"10.1016\/j.micpath.2022.105622_bib3","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1089\/aid.2011.0248","article-title":"Human T-lymphotropic virus type 1 prevalence in northeastern Iran, Sabzevar: an epidemiologic-based study and phylogenetic analysis","volume":"28","author":"Azarpazhooh","year":"2012","journal-title":"AIDS Res. Hum. Retrovir."},{"issue":"3","key":"10.1016\/j.micpath.2022.105622_bib4","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jcv.2011.07.004","article-title":"High prevalence of HTLV-I infection in Mashhad, Northeast Iran: a population-based seroepidemiology survey","volume":"52","author":"Rafatpanah","year":"2011","journal-title":"J. Clin. Virol. : Off. Publ. Pan Am. Soc. Clin. Virol."},{"issue":"3","key":"10.1016\/j.micpath.2022.105622_bib5","first-page":"232","article-title":"Population-based seroprevalence of HTLV-I infection in golestan province, South East of Caspian Sea, Iran","volume":"16","author":"Tabarraei","year":"2013","journal-title":"IJBMS"},{"issue":"2","key":"10.1016\/j.micpath.2022.105622_bib6","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1182\/blood.V75.2.428.428","article-title":"High human T-cell lymphotropic virus type I proviral DNA load with polyclonal integration in peripheral blood mononuclear cells of French West Indian, Guianese, and African patients with tropical spastic paraparesis","volume":"75","author":"Gessain","year":"1990","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.micpath.2022.105622_bib7","first-page":"153","article-title":"HTLV-I Infection: virus structure, immune response to the virus and genetic association studies in HTLV-I-infected individuals","volume":"5","author":"Rafatpanah","year":"2006","journal-title":"Iran. J. Allergy, Asthma Immunol."},{"issue":"6","key":"10.1016\/j.micpath.2022.105622_bib8","first-page":"485","article-title":"HTLV-1 infection: an emerging risk. Pathogenesis, epidemiology, diagnosis and associated diseases","volume":"32","author":"Eusebio-Ponce","year":"2019","journal-title":"Rev. Espa\u00f1ola Quimioter. : publicacion oficial de la Sociedad Espanola de Quimioterapia"},{"issue":"3","key":"10.1016\/j.micpath.2022.105622_bib9","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/00126334-200207010-00016","article-title":"Clinical impact of HTLV-1 infection in Spain: implications for public health and mandatory screening","volume":"30","author":"Toro","year":"2002","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.micpath.2022.105622_bib10","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/978-3-642-85459-0_59","article-title":"[Political public health measures and aspects in the control of HTLV-III infection]","volume":"92","author":"Steinbach","year":"1986","journal-title":"Verhandlungen der Deutschen Gesellschaft fur Innere Medizin"},{"issue":"3","key":"10.1016\/j.micpath.2022.105622_bib11","first-page":"196","article-title":"A systematic review for estimation of HTLV-I infection in the blood donors of Iran","volume":"16","author":"Hedayati-Moghaddam","year":"2013","journal-title":"IJBMS"},{"issue":"12","key":"10.1016\/j.micpath.2022.105622_bib12","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1089\/aid.1996.12.1185","article-title":"Prevalence of HTLV type I infection in Iran: a serological and genetic study","volume":"12","author":"Safai","year":"1996","journal-title":"AIDS Res. Hum. Retrovir."},{"issue":"9","key":"10.1016\/j.micpath.2022.105622_bib13","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1089\/aid.2011.0248","article-title":"Human T-lymphotropic virus type 1 prevalence in northeastern Iran, Sabzevar: an epidemiologic-based study and phylogenetic analysis","volume":"28","author":"Azarpazhooh","year":"2012","journal-title":"AIDS Res. Hum. Retrovir."},{"issue":"6","key":"10.1016\/j.micpath.2022.105622_bib14","first-page":"424","article-title":"Epidemiology of HTLV-1 in Neyshabour, northeast of Iran","volume":"13","author":"Hedayati-Moghaddam","year":"2011","journal-title":"Iran. Red Crescent Med. J."},{"issue":"1","key":"10.1016\/j.micpath.2022.105622_bib15","first-page":"57","article-title":"Houshang rafatpanah, and Amir tafreshian prevalence of HTLV-I infection in patients with thalassemia major in Mazandaran, North of Iran","volume":"6","author":"Javad Ghaffari","year":"2012","journal-title":"jjm"},{"issue":"Suppl 1","key":"10.1016\/j.micpath.2022.105622_bib16","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.1097\/00042560-199600001-00021","article-title":"Molecular epidemiology of HTLV-I in the world","volume":"13","author":"Yamashita","year":"1996","journal-title":"J. Acq. Immune Def.Syndr. Human Retrovirol. Off. Publ. Int. Retrovirol. Assoc."},{"issue":"39","key":"10.1016\/j.micpath.2022.105622_bib17","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1038\/sj.onc.1208968","article-title":"Global epidemiology of HTLV-I infection and associated diseases","volume":"24","author":"Proietti","year":"2005","journal-title":"Oncogene"},{"issue":"388","key":"10.1016\/j.micpath.2022.105622_bib18","article-title":"Epidemiological aspects and world distribution of HTLV-1 infection","volume":"3","author":"Gessain","year":"2012","journal-title":"Front. Microbiol."},{"issue":"5","key":"10.1016\/j.micpath.2022.105622_bib19","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1349-7006.1989.tb02327.x","article-title":"Effect of freeze-thawing breast milk on vertical HTLV-I transmission from seropositive mothers to children","volume":"80","author":"Ando","year":"1989","journal-title":"Jpn. J. Cancer Res. : Gann"},{"issue":"4","key":"10.1016\/j.micpath.2022.105622_bib20","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/(SICI)1096-9071(199912)59:4<541::AID-JMV19>3.0.CO;2-S","article-title":"Estimating the time of HTLV-I infection following mother-to-child transmission in a breast-feeding population in Jamaica","volume":"59","author":"Furnia","year":"1999","journal-title":"J. Med. Virol."},{"issue":"4","key":"10.1016\/j.micpath.2022.105622_bib21","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1442-200X.1989.tb01329.x","article-title":"Milk-borne transmission of HTLV-I as a major route in the endemic cycle","volume":"31","author":"Hino","year":"1989","journal-title":"Acta paediatrica Japonica; Overseas edition"},{"issue":"7","key":"10.1016\/j.micpath.2022.105622_bib22","first-page":"674","article-title":"Milk-borne transmission of HTLV-I from carrier mothers to their children","volume":"78","author":"Kinoshita","year":"1987","journal-title":"Jpn. J. Cancer Res. : Gann"},{"issue":"3","key":"10.1016\/j.micpath.2022.105622_bib23","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/jcla.1860080307","article-title":"Anti-HTLV-I IgG in urine detected by sensitive enzyme immunoassay (immune complex transfer enzyme immunoassay) using a synthetic peptide, Cys-env gp46(188-224), as antigen","volume":"8","author":"Hashida","year":"1994","journal-title":"J. Clin. Lab. Anal."},{"issue":"10","key":"10.1016\/j.micpath.2022.105622_bib24","first-page":"876","article-title":"[Discussion. Consequences of the research on re-evaluation of public heath activities]","volume":"40","author":"Okochi","year":"1984","journal-title":"Hokenfu Zasshi"},{"issue":"1","key":"10.1016\/j.micpath.2022.105622_bib25","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ijc.2910440111","article-title":"Patterns of migration indicate sexual transmission of HTLV-I infection in non-pregnant women in Papua New Guinea","volume":"44","author":"Brabin","year":"1989","journal-title":"Int. J. Canc. J. Int. Du Canc."},{"issue":"5613","key":"10.1016\/j.micpath.2022.105622_bib26","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1126\/science.1080115","article-title":"Bangham. Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton","volume":"299","author":"Igakura","year":"2003","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.micpath.2022.105622_bib27","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0092-8674(03)00881-X","article-title":"The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV","volume":"115","author":"Manel","year":"2003","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.micpath.2022.105622_bib28","first-page":"974","article-title":"Prevention of HTLV-I transmission through the breast milk by a freeze-thawing process","volume":"77","author":"Ando","year":"1986","journal-title":"Jpn. J. Cancer Res. : Gann"},{"issue":"3","key":"10.1016\/j.micpath.2022.105622_bib29","first-page":"135","article-title":"Risk factors for HTLV-I mother to child transmission: influence of genetic markers","volume":"2","author":"Arango","year":"1998","journal-title":"Braz. J. Infect. Dis. : Off. Publ. Braz. Soc. Infect. Dis."},{"issue":"19","key":"10.1016\/j.micpath.2022.105622_bib30","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1001\/jama.1987.03390190082024","article-title":"Transmission of HTLV-I and HIV among homosexual men in Trinidad","volume":"257","author":"Bartholomew","year":"1987","journal-title":"JAMA : J. Am. Med. Assoc."},{"issue":"3\u20134","key":"10.1016\/j.micpath.2022.105622_bib31","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3109\/10428199809059235","article-title":"HTLV-I infection among relatives of patients with adult T-cell leukemia\/lymphoma in Brazil: analysis of infection transmission","volume":"31","author":"Borducchi","year":"1998","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.micpath.2022.105622_bib32","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1101\/gr.9.6.525","article-title":"Genomic evolution, patterns of global dissemination, and interspecies transmission of human and simian T-cell leukemia\/lymphotropic viruses","author":"Jill Pecon Slattery","year":"1999","journal-title":"Genome Res."},{"issue":"2","key":"10.1016\/j.micpath.2022.105622_bib33","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3201\/eid1502.080584","article-title":"Simian T-lymphotropic virus diversity among nonhuman primates, Cameroon","volume":"15","author":"Sintasath","year":"2009","journal-title":"Emerg. Infect. Dis."},{"issue":"3","key":"10.1016\/j.micpath.2022.105622_bib34","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1073\/pnas.91.3.1124","article-title":"Phylogenetic subtypes of human T-lymphotropic virus type I and their relations to the anthropological background Phylogeny of HTLV-I isolates from groups with risk antecedents for human retrovirus infections in Argentina","volume":"91","author":"Miura","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"6","key":"10.1016\/j.micpath.2022.105622_bib35","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1089\/aid.2011.0211","article-title":"Identification and molecular characterization of new simian T cell lymphotropic viruses in nonhuman primates bushmeat from the democratic republic of Congo","volume":"28","author":"Ahuka-Mundeke","year":"2012","journal-title":"AIDS Res. Hum. Retrovir."},{"issue":"5","key":"10.1016\/j.micpath.2022.105622_bib36","doi-asserted-by":"crossref","first-page":"830","DOI":"10.3201\/eid1805.111663","article-title":"Origin of human T-lymphotropic virus type 1 in rural C?te d'Ivoire","volume":"18","author":"Calvignac-Spencer","year":"2012","journal-title":"Emerg. Infect. Dis."},{"issue":"11","key":"10.1016\/j.micpath.2022.105622_bib37","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1128\/JCM.01249-08","article-title":"New insights into prevalence, genetic diversity, and proviral load of human T-cell leukemia virus types 1 and 2 in pregnant women in Gabon in equatorial central Africa","volume":"46","author":"Etenna","year":"2008","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.micpath.2022.105622_bib38","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/1471-2148-10-314","article-title":"The imprint of the slave trade in an African American population: mitochondrial DNA, Y chromosome and HTLV-1 analysis in the noir marron of French guiana","volume":"10","author":"Brucato","year":"2010","journal-title":"BMC Evol. Biol."},{"issue":"6","key":"10.1016\/j.micpath.2022.105622_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001690","article-title":"Molecular epidemiology of endemic human T-lymphotropic virus type 1 in a rural community in Guinea-bissau","volume":"6","author":"van Tienen","year":"2012","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"9","key":"10.1016\/j.micpath.2022.105622_bib40","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1089\/aid.2011.0248","article-title":"Human T-lymphotropic virus type 1 prevalence in northeastern Iran, Sabzevar: an epidemiologic-based study and phylogenetic analysis","volume":"28","author":"Azarpazhooh","year":"2012","journal-title":"AIDS Res. Hum. Retrovir."},{"issue":"4","key":"10.1016\/j.micpath.2022.105622_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001038","article-title":"Genetic characterization of human T-cell lymphotropic virus type 1 in Mozambique: transcontinental lineages drive the HTLV-1 endemic","volume":"5","author":"Vicente","year":"2011","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"12","key":"10.1016\/j.micpath.2022.105622_bib42","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1002\/jmv.21834","article-title":"Stable human T-cell lymphotropic virus type 1 (HTLV-1) subtype a\/subgroup a endemicity in Amerindians from Northwest Argentina: a health problem to be resolved","volume":"82","author":"Eirin","year":"2010","journal-title":"J. Med. Virol."},{"issue":"3","key":"10.1016\/j.micpath.2022.105622_bib43","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1089\/aid.2010.0195","article-title":"Molecular characterization of human T cell leukemia virus type 1 subtypes in a group of infected individuals diagnosed in Portugal and Spain","volume":"27","author":"P\u00e1dua","year":"2011","journal-title":"AIDS Res. Hum. Retrovir."},{"issue":"4","key":"10.1016\/j.micpath.2022.105622_bib44","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1086\/596206","article-title":"New strain of human T lymphotropic virus (HTLV) type 3 in a Pygmy from Cameroon with peculiar HTLV serologic results","volume":"199","author":"Calattini","year":"2009","journal-title":"J. Infect. Dis."},{"issue":"10","key":"10.1016\/j.micpath.2022.105622_bib45","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1586\/eri.09.97","article-title":"Discovery and significance of new human T-lymphotropic viruses: HTLV-3 and HTLV-4","volume":"7","author":"Bagossi","year":"2009","journal-title":"Expert Rev. Anti Infect. Ther."},{"issue":"5","key":"10.1016\/j.micpath.2022.105622_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/v8050132","article-title":"Distinct morphology of human T-cell leukemia virus type 1-like particles","volume":"8","author":"Maldonado","year":"2016","journal-title":"Viruses"},{"issue":"75","key":"10.1016\/j.micpath.2022.105622_bib47","first-page":"1742","article-title":"Biophysical analysis of HTLV-1 particles reveals novel insights into particle morphology and Gag stochiometry","volume":"7","author":"Grigsby","year":"2010","journal-title":"Retrovirology"},{"issue":"4","key":"10.1016\/j.micpath.2022.105622_bib48","first-page":"153","article-title":"HTLV-I infection: virus structure, immune response to the virus and genetic association studies in HTLV-I-infected individuals","volume":"5","author":"Houshang Rafatpanah","year":"2006","journal-title":"Iran. J. Allergy, Asthma Immunol."},{"issue":"7","key":"10.1016\/j.micpath.2022.105622_bib49","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.3390\/v3071131","article-title":"Molecular determinants of human T-lymphotropic virus type 1 transmission and spread","volume":"3","author":"Lairmore","year":"2011","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.micpath.2022.105622_bib50","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2222\/jsv.62.113","article-title":"[HTLV-1 pathogenesis mediated by HTLV-1 bZIP factor]","volume":"62","author":"Satou","year":"2012","journal-title":"Uirusu"},{"issue":"5","key":"10.1016\/j.micpath.2022.105622_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002251","article-title":"Human T-lymphotropic virus-1 visualized at the virological synapse by electron tomography","volume":"3","author":"Majorovits","year":"2008","journal-title":"PLoS One"},{"issue":"Suppl 1","key":"10.1016\/j.micpath.2022.105622_bib52","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1097\/00042560-199600001-00015","article-title":"The HTLV-I envelope glycoproteins: structure and functions","volume":"13","author":"Delamarre","year":"1996","journal-title":"J. Acq. Immune Def.Syndr. Human Retrovirol. Off. Publ. Int. Retrovirol. Assoc."},{"issue":"6","key":"10.1016\/j.micpath.2022.105622_bib53","first-page":"428","article-title":"Khorasan disease: prevalence of HTLV-I associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) in west azarbaijan from 2004 to 2007","volume":"13","author":"Boostani","year":"2011","journal-title":"Iran. Red Crescent Med. J."},{"key":"10.1016\/j.micpath.2022.105622_bib54","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1742-4690-5-96","article-title":"Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP)","volume":"5","author":"Burbelo","year":"2008","journal-title":"Retrovirology"},{"issue":"2","key":"10.1016\/j.micpath.2022.105622_bib55","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000139130","article-title":"HTLV-I production based on activation of integrin\/ligand signaling in HTLV-I-infected T cell lines derived from HAM\/TSP patients","volume":"51","author":"Fukushima","year":"2008","journal-title":"Intervirology"},{"issue":"2","key":"10.1016\/j.micpath.2022.105622_bib56","first-page":"94","article-title":"Association between HLA-DRB1*01 and HLA-Cw*08 and outcome following HTLV-I infection","volume":"4","author":"Rafatpanah","year":"2007","journal-title":"Iranian J. Immunol. : IJI"},{"key":"10.1016\/j.micpath.2022.105622_bib57","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2334-4-7","article-title":"Exacerbated inflammatory cellular immune response characteristics of HAM\/TSP is observed in a large proportion of HTLV-I asymptomatic carriers","volume":"4","author":"Santos","year":"2004","journal-title":"BMC Infect. Dis."},{"issue":"1","key":"10.1016\/j.micpath.2022.105622_bib58","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF01718595","article-title":"Detection of proviral human T-cell lymphotrophic virus type I DNA in mouthwash samples of HAM\/TSP patients and HTLV-I carriers","volume":"141","author":"Achiron","year":"1996","journal-title":"Arch. Virol."},{"issue":"3","key":"10.1016\/j.micpath.2022.105622_bib59","first-page":"202","article-title":"HTLV-I infection\u201d twenty-year research in neurology department of Mashhad university of medical Sciences","volume":"16","author":"Ali Shoeibi","year":"2013","journal-title":"IJBMS"},{"issue":"1","key":"10.1016\/j.micpath.2022.105622_bib60","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3851\/IMP1699","article-title":"Fucoidan therapy decreases the proviral load in patients with human T-lymphotropic virus type-1-associated neurological disease","volume":"16","author":"Araya","year":"2011","journal-title":"Antivir. Ther."},{"issue":"4","key":"10.1016\/j.micpath.2022.105622_bib61","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1212\/WNL.46.4.1016","article-title":"Interferon-alpha is effective in HTLV-I-associated myelopathy: a multicenter, randomized, double-blind, controlled trial","volume":"46","author":"Izumo","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.micpath.2022.105622_bib62","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jneuroim.2012.05.004","article-title":"The impact of interferon-alpha treatment on clinical and immunovirological aspects of HTLV-I-associated myelopathy in northeast of Iran","volume":"250","author":"Rafatpanah","year":"2012","journal-title":"Neuroimmunol"},{"issue":"3","key":"10.1016\/j.micpath.2022.105622_bib63","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1346-8138.1997.tb02765.x","article-title":"A case of adult T-cell leukemia\/lymphoma (ATLL) with angiocentric and angiodestructive features","volume":"24","author":"Ohtake","year":"1997","journal-title":"J. Dermatol."},{"issue":"12","key":"10.1016\/j.micpath.2022.105622_bib64","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1182\/blood-2011-11-390807","article-title":"Quantitative differences in HTLV-I antibody responses: classification and relative risk assessment for asymptomatic carriers and ATL and HAM\/TSP patients from Jamaica","volume":"119","author":"Enose-Akahata","year":"2012","journal-title":"Blood"},{"issue":"1\u20132","key":"10.1016\/j.micpath.2022.105622_bib65","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jneuroim.2012.05.004","article-title":"The impact of interferon-alpha treatment on clinical and immunovirological aspects of HTLV-1-associated myelopathy in northeast of Iran","volume":"250","author":"Rafatpanah","year":"2012","journal-title":"J. Neuroimmunol."},{"issue":"8","key":"10.1016\/j.micpath.2022.105622_bib66","doi-asserted-by":"crossref","first-page":"9931","DOI":"10.3390\/molecules17089931","article-title":"The bioassay-guided isolation of growth inhibitors of adult T-cell leukemia (ATL), from the Jamaican plant Hyptis verticillata, and NMR characterization of hyptoside","volume":"17","author":"Hamada","year":"2012","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.micpath.2022.105622_bib67","first-page":"1063","article-title":"[Cardiac invasion of ATLL cells and therapeutic effects of local along with systemic treatments]","volume":"30","author":"Imoto","year":"1989","journal-title":"[Rinsho Ketsueki] Jpn J. Clin. Hematol."},{"issue":"8","key":"10.1016\/j.micpath.2022.105622_bib68","first-page":"497","article-title":"Guillain-Barre-like syndrome, as a rare presentation of adult T-cell leukemia-lymphoma (ATLL): a case report","volume":"14","author":"Sasannejad","year":"2012","journal-title":"Iran. Red Crescent Med. J."},{"issue":"1\u20132","key":"10.1016\/j.micpath.2022.105622_bib69","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jns.2007.07.028","article-title":"Enlarged, multifocal upper limb neuropathy with HTLV-I associated myelopathy in a patient with chronic adult T-cell leukemia","volume":"266","author":"Umehara","year":"2008","journal-title":"J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.micpath.2022.105622_bib70","first-page":"423","article-title":"Estimation of rate of incidence of ATL among ATLV (HTLV-I) carriers in Kyushu, Japan","volume":"15","author":"Tajima","year":"1985","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.micpath.2022.105622_bib71","volume":"vol. 2012","author":"Tsukasaki","year":"2012"},{"issue":"5","key":"10.1016\/j.micpath.2022.105622_bib72","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1158\/1535-7163.MCT-11-0850","article-title":"JAK-STAT and JAK-PI3K-mTORC1 pathways regulate telomerase transcriptionally and posttranslationally in ATL cells","volume":"11","author":"Yamada","year":"2012","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.micpath.2022.105622_bib73","volume":"vol. 2012","author":"Satou","year":"2012"},{"key":"10.1016\/j.micpath.2022.105622_bib74","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1742-4690-9-115","article-title":"WIP1 deficiency inhibits HTLV-1 Tax oncogenesis: novel therapeutic prospects for treatment of ATL?","volume":"9","author":"Gillet","year":"2012","journal-title":"Retrovirology"},{"issue":"6","key":"10.1016\/j.micpath.2022.105622_bib75","first-page":"1069","article-title":"Role of tumor suppressor genes in the development of adult T cell leukemia\/lymphoma (ATLL). Leukemia","volume":"16","author":"Hatta","year":"2002","journal-title":"Off. J. Leukemia Soc. Am. Leukemia Res. Fund"},{"issue":"27","key":"10.1016\/j.micpath.2022.105622_bib76","doi-asserted-by":"crossref","first-page":"5207","DOI":"10.1016\/j.febslet.2007.10.008","article-title":"IL-2 withdrawal induces HTLV-1 expression through p38 activation in ATL cell lines","volume":"581","author":"Washiyama","year":"2007","journal-title":"FEBS Lett."},{"issue":"11","key":"10.1016\/j.micpath.2022.105622_bib77","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001177","article-title":"HTLV-1 evades type I interferon antiviral signaling by inducing the suppressor of cytokine signaling 1 (SOCS1)","volume":"6","author":"Oliere","year":"2010","journal-title":"PLoS Pathog."},{"issue":"6","key":"10.1016\/j.micpath.2022.105622_bib78","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/j.tripleo.2010.02.021","article-title":"A case of ATLL (adult T-cell leukemia\/lymphoma) mimicking odontogenic infection","volume":"109","author":"Yamada","year":"2010","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"issue":"4","key":"10.1016\/j.micpath.2022.105622_bib79","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0009-9260(96)80352-7","article-title":"Case report: multiple lytic lesions in HTLV1 associated ATLL in the absence of lymphadenopathy and peripheral blood changes","volume":"51","author":"Kessar","year":"1996","journal-title":"Clin. Radiol."},{"issue":"4","key":"10.1016\/j.micpath.2022.105622_bib80","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/(SICI)1097-0215(19970807)72:4<592::AID-IJC7>3.0.CO;2-L","article-title":"Clonal HTLV-I-infected CD4+ T-lymphocytes and non-clonal non-HTLV-I-infected giant cells in incipient ATLL with Hodgkin-like histologic features","volume":"72","author":"Ohshima","year":"1997","journal-title":"Int. J. Canc. J. Int. Du Canc."},{"issue":"6","key":"10.1016\/j.micpath.2022.105622_bib81","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/00000372-198812000-00003","article-title":"Angiocentric and angiodestructive infiltration of adult T-cell leukemia\/lymphoma (ATLL) in the skin. Report of two cases","volume":"10","author":"Manabe","year":"1988","journal-title":"Am. J. Dermatopathol."},{"issue":"5","key":"10.1016\/j.micpath.2022.105622_bib82","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1365-2133.1989.tb08192.x","article-title":"Characterization of skin infiltrating cells in adult T-cell leukaemia\/lymphoma (ATLL): clinical, histological and immunohistochemical studies on eight cases","volume":"121","author":"Maeda","year":"1989","journal-title":"Br. J. Dermatol."},{"issue":"9","key":"10.1016\/j.micpath.2022.105622_bib83","first-page":"1405","article-title":"A comparative microphotometric analysis of adult T-cell leukemia\/lymphoma (ATLL) in the skin and mycosis fungoides (MF)","volume":"37","author":"Hasui","year":"1987","journal-title":"Acta Pathol. Jpn."},{"issue":"4","key":"10.1016\/j.micpath.2022.105622_bib84","first-page":"341","article-title":"Metastatic calcification due to hypercalcemia in adult T-cell leukemia-lymphoma (ATLL)","volume":"137","author":"Senba","year":"1991","journal-title":"Zentralblatt fur Pathologie"},{"issue":"4","key":"10.1016\/j.micpath.2022.105622_bib85","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jcv.2010.05.005","article-title":"Flower cells in patients with infective dermatitis associated with HTLV-1","volume":"48","author":"de Oliveira Mde","year":"2010","journal-title":"J. Clin. Virol. : Off. Publ. Pan Am. Soc. Clin. Virol."},{"issue":"1","key":"10.1016\/j.micpath.2022.105622_bib86","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2169\/internalmedicine.41.34","article-title":"Adult T-cell leukemia (ATL) cells which express neural cell adhesion molecule (NCAM) and infiltrate into the central nervous system","volume":"41","author":"Hashiguchi","year":"2002","journal-title":"Intern. Med."},{"issue":"5\u20136","key":"10.1016\/j.micpath.2022.105622_bib87","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3109\/10428199609054793","article-title":"Adult T-cell leukemia (ATL) with an unusual immunophenotype and a high cellular proliferation rate","volume":"22","author":"Lorand-Metze","year":"1996","journal-title":"Leuk. Lymphoma"},{"issue":"4","key":"10.1016\/j.micpath.2022.105622_bib88","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1080\/02841860802657235","article-title":"Adult T-cell leukemia\/lymphoma (ATL) presenting in the skin: clinical, histological and immunohistochemical features of 52 cases","volume":"48","author":"Bittencourt","year":"2009","journal-title":"Acta Oncol."},{"issue":"5","key":"10.1016\/j.micpath.2022.105622_bib89","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1600-0625.1992.tb00084.x","article-title":"Adult T-cell leukemia\/lymphoma (ATL)--clinical, histopathological, immunological and immunohistochemical characteristics","volume":"1","author":"Nagatani","year":"1992","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.micpath.2022.105622_bib90","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1743-422X-7-81","article-title":"High human T cell leukemia virus type-1(HTLV-1) provirus load in patients with HTLV-1 carriers complicated with HTLV-1-unrelated disorders","volume":"7","author":"Sasaki","year":"2010","journal-title":"Virol. J."},{"issue":"5","key":"10.1016\/j.micpath.2022.105622_bib91","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1002\/ijc.22767","article-title":"Risk of human T-lymphotropic virus type I-associated diseases in Jamaica with common HLA types","volume":"121","author":"Goedert","year":"2007","journal-title":"Int. J. Canc. J. Int. Du Canc."},{"key":"10.1016\/j.micpath.2022.105622_bib92","first-page":"208","article-title":"Comparison of HTLV-I proviral load in adult T cell leukemia\/lymphoma (ATL), HTLV-I-associated myelopathy (HAM-TSP) and healthy carriers","volume":"16","author":"Mohammad Mehdi Akbarin","year":"2013","journal-title":"Iran J Basic Med Sci"},{"issue":"6","key":"10.1016\/j.micpath.2022.105622_bib93","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.leukres.2006.11.013","article-title":"Impact of visceral involvements and blood cell count abnormalities on survival in adult T-cell leukemia\/lymphoma (ATLL)","volume":"31","author":"Takasaki","year":"2007","journal-title":"Leuk. Res."},{"issue":"1","key":"10.1016\/j.micpath.2022.105622_bib94","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1182\/blood-2012-11-464628","article-title":"GVL for ATL?","volume":"121","author":"Shah","year":"2013","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.micpath.2022.105622_bib95","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s11899-012-0139-9","article-title":"Antivirals\" in the treatment of adult T cell leukaemia- lymphoma (ATLL)","volume":"7","author":"Fields","year":"2012","journal-title":"Curr. Hematol. Malig. Rep."},{"issue":"10","key":"10.1016\/j.micpath.2022.105622_bib96","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1182\/blood-2004-11-4193","article-title":"Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for adult T-cell leukemia\/lymphoma","volume":"105","author":"Okamura","year":"2005","journal-title":"Blood"},{"issue":"3\u20134","key":"10.1016\/j.micpath.2022.105622_bib97","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3109\/10428199809068577","article-title":"Granulocyte colony-stimulating factor in the combination chemotherapy for adult T-cell leukemia (ATL)","volume":"29","author":"Uozumi","year":"1998","journal-title":"Leuk. Lymphoma"},{"issue":"2","key":"10.1016\/j.micpath.2022.105622_bib98","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1590\/S0037-86822008000200003","article-title":"[HTLV 1\/2 infection: prenatal performance as a disease control strategy in State of Mato Grosso do Sul]","volume":"41","author":"Dal Fabbro","year":"2008","journal-title":"Rev. Soc. Bras. Med. Trop."},{"issue":"1","key":"10.1016\/j.micpath.2022.105622_bib99","first-page":"15","article-title":"Effect of human T-cell lymphotrophic virus type 1 (HTLV-1) in seropositive infertile women on intracytoplasmic sperm injection (ICSI) outcome","volume":"12","author":"Mansouri Torshizi","year":"2014","journal-title":"Iran. J. Reproductive Med."},{"issue":"4","key":"10.1016\/j.micpath.2022.105622_bib100","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1590\/S0037-86822012005000007","article-title":"Descriptive study of HTLV infection in a population of pregnant women from the state of Para, Northern Brazil","volume":"45","author":"Sequeira","year":"2012","journal-title":"Rev. Soc. Bras. Med. Trop."},{"issue":"3","key":"10.1016\/j.micpath.2022.105622_bib101","first-page":"217","article-title":"Human T lymphotropic virus type I (HTLV-I) is a risk factor for coronary artery disease","volume":"16","author":"Farid Hosseni","year":"2013","journal-title":"Ir. J. Basic Med. Sci."},{"issue":"8","key":"10.1016\/j.micpath.2022.105622_bib102","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8081109","article-title":"Inflammation as a therapeutic target in atherosclerosis","volume":"8","author":"Nguyen","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.micpath.2022.105622_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2019.103578","article-title":"HTLV-1-host interactions facilitate the manifestations of cardiovascular disease","volume":"134","author":"Mohammadi","year":"2019","journal-title":"Microb. Pathog."},{"issue":"7","key":"10.1016\/j.micpath.2022.105622_bib104","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1002\/1097-0142(19901001)66:7<1524::AID-CNCR2820660715>3.0.CO;2-N","article-title":"Acute T-cell leukemia\/lymphoma mimicking Hodgkin's disease with secondary HTLV I seroconversion","volume":"66","author":"Picard","year":"1990","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.micpath.2022.105622_bib105","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1182\/blood.V71.4.1027.1027","article-title":"HTLV-I-induced lymphoma mimicking Hodgkin's disease. Diagnosis by polymerase chain reaction amplification of specific HTLV-I sequences in tumor DNA","volume":"71","author":"Duggan","year":"1988","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.micpath.2022.105622_bib106","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1440-1827.1997.tb04461.x","article-title":"Epstein-Barr virus-related Hodgkin's disease showing B cell lineage in an immunosuppressive patient seropositive for HTLV-I","volume":"47","author":"Murata","year":"1997","journal-title":"Pathol. Int."},{"issue":"1","key":"10.1016\/j.micpath.2022.105622_bib107","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1182\/blood.V89.1.346","article-title":"Extensive latent retroviral infection in bone marrow of patients with HTLV-I-associated neurologic disease","volume":"89","author":"Levin","year":"1997","journal-title":"Blood"},{"issue":"5\u20136","key":"10.1016\/j.micpath.2022.105622_bib108","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3109\/10428199109068088","article-title":"Analysis of HTLV-I in Hodgkin's disease","volume":"4","author":"Tesch","year":"1991","journal-title":"Leuk. Lymphoma"},{"issue":"1","key":"10.1016\/j.micpath.2022.105622_bib109","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1440-1827.1998.tb03831.x","article-title":"Epstein-Barr virus-associated Hodgkin's disease in HTLV-I seropositive patients: a report of two cases","volume":"48","author":"Sadahira","year":"1998","journal-title":"Pathol. Int."},{"issue":"10","key":"10.1016\/j.micpath.2022.105622_bib110","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2169\/internalmedicine.35.753","article-title":"Recurrence of Kikuchi's disease with aseptic meningitis in HTLV-1 carrier","volume":"35","author":"Kikuchi","year":"1996","journal-title":"Intern. Med."},{"issue":"2","key":"10.1016\/j.micpath.2022.105622_bib111","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1590\/S0037-86822007000200007","article-title":"[Frequency of HIV-1, rubella, syphilis, toxoplasmosis, cytomegalovirus, simple herpes virus, hepatitis B, hepatitis C, Chagas disease and HTLV I\/II infection in pregnant women of State of Mato Grosso do Sul]","volume":"40","author":"Figueiro-Filho","year":"2007","journal-title":"Rev. Soc. Bras. Med. Trop."},{"issue":"11","key":"10.1016\/j.micpath.2022.105622_bib112","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1089\/aid.2015.0340","article-title":"Association of tuberculosis status with neurologic disease and immune response in HTLV-1 infection","volume":"33","author":"Souza","year":"2017","journal-title":"AIDS Res. Hum. Retrovir."},{"issue":"3","key":"10.1016\/j.micpath.2022.105622_bib113","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jcv.2011.12.018","article-title":"Helminthic infection and the risk of neurologic disease progression in HTLV-1","volume":"53","author":"Sundberg","year":"2012","journal-title":"J. Clin. Virol. : Off. Publ. Pan Am. Soc. Clin. Virol."},{"issue":"4","key":"10.1016\/j.micpath.2022.105622_bib114","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1600-0404.1987.tb07925.x","article-title":"Serum antibodies to HTLV-I in human demyelinating disease","volume":"75","author":"Epstein","year":"1987","journal-title":"Acta Neurol. Scand."},{"issue":"5\u20136","key":"10.1016\/j.micpath.2022.105622_bib115","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000110277","article-title":"Multiple sclerosis as a retroviral disease? Epidemiological considerations in relation to HTLV-I epidemiology","volume":"10","author":"Haahr","year":"1991","journal-title":"Neuroepidemiology"},{"issue":"1","key":"10.1016\/j.micpath.2022.105622_bib116","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0022-510X(97)00199-8","article-title":"Lack of evidence for HTLV tax-rex DNA in motor neurone disease","volume":"153","author":"Andrews","year":"1997","journal-title":"J. Neurol. Sci."},{"issue":"3","key":"10.1016\/j.micpath.2022.105622_bib117","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1086\/314923","article-title":"HTLV-I\/II seroindeterminate Western blot reactivity in a cohort of patients with neurological disease","volume":"180","author":"Soldan","year":"1999","journal-title":"J. Infect. Dis."},{"issue":"4","key":"10.1016\/j.micpath.2022.105622_bib118","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1590\/S1980-57642013DN74000014","article-title":"Encephalomyelopathy associated with HTLV-I a primary disease or coexisting with multiple sclerosis?","volume":"7","author":"Champs","year":"2013","journal-title":"Dementia Neuropsychol."},{"issue":"9","key":"10.1016\/j.micpath.2022.105622_bib119","first-page":"1060","article-title":"[Neurophysiological studies of minamata disease with HTLV-I associated myelopathy--a case report]","volume":"36","author":"Nakanishi","year":"1996","journal-title":"Rinsho shinkeigaku = Clinical neurology"},{"issue":"6","key":"10.1016\/j.micpath.2022.105622_bib120","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1182\/blood.V80.6.1537.1537","article-title":"Human lymphotropic retroviruses associated with mycosis fungoides: evidence that human T-cell lymphotropic virus type II (HTLV-II) as well as HTLV-I may play a role in the disease","volume":"80","author":"Zucker-Franklin","year":"1992","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.micpath.2022.105622_bib121","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1089\/aid.1994.10.1173","article-title":"Cutaneous disease resembling mycosis fungoides in HIV-infected patients whose skin and blood cells also harbor proviral HTLV type I","volume":"10","author":"Zucker-Franklin","year":"1994","journal-title":"AIDS Res. Hum. Retrovir."},{"issue":"3","key":"10.1016\/j.micpath.2022.105622_bib122","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/0002-9343(91)90132-H","article-title":"Syndrome of severe skin disease, eosinophilia, and dermatopathic lymphadenopathy in patients with HTLV-II complicating human immunodeficiency virus infection","volume":"91","author":"Kaplan","year":"1991","journal-title":"Am. J. Med."},{"issue":"7","key":"10.1016\/j.micpath.2022.105622_bib123","first-page":"859","article-title":"[Cutaneous manifestations detected in human T cell lymphotropic virus type 1 infected Chilean blood donors]","volume":"142","author":"Garcia-Huidobro","year":"2014","journal-title":"Rev. Med. Chile"},{"issue":"1","key":"10.1016\/j.micpath.2022.105622_bib124","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2008.03834.x","article-title":"The role of infections in autoimmune disease","volume":"155","author":"Ercolini","year":"2009","journal-title":"Clin. Exp. Immunol."},{"issue":"3","key":"10.1016\/j.micpath.2022.105622_bib125","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1189\/jlb.0709517","article-title":"Infections and autoimmunity: the multifaceted relationship","volume":"87","author":"Sfriso","year":"2010","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.micpath.2022.105622_bib126","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.2741\/1414","article-title":"Immunopathogensis of HTLV-I associated neurologic disease: molecular, histopathologic, and immunologic approaches","volume":"9","author":"Takenouchi","year":"2004","journal-title":"Front. Biosci. : J. Vis. Literacy"},{"issue":"1","key":"10.1016\/j.micpath.2022.105622_bib127","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0022-510X(93)90200-I","article-title":"Behcet's disease and Sjogren syndrome in a patient with HTLV-I-associated myelopathy","volume":"119","author":"Kanazawa","year":"1993","journal-title":"J. Neurol. Sci."},{"issue":"8","key":"10.1016\/j.micpath.2022.105622_bib128","first-page":"912","article-title":"[Myelopathy with uveitis in association with HTLV-I mimicking neuro-Behcet's disease]","volume":"33","author":"Saito","year":"1993","journal-title":"Rinsho shinkeigaku = Clinical neurology"},{"issue":"6","key":"10.1016\/j.micpath.2022.105622_bib129","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s10067-004-0955-y","article-title":"Mixed connective tissue disease with interstitial pneumonia in HTLV-1 carrier: case report and review of the literature","volume":"23","author":"Shimojima","year":"2004","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.micpath.2022.105622_bib130","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s12879-015-1002-0","article-title":"High prevalence of bronchiectasis is linked to HTLV-1-associated inflammatory disease","volume":"15","author":"Honarbakhsh","year":"2015","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.micpath.2022.105622_bib131","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1742-4690-2-4","article-title":"Increased proviral load in HTLV-1-infected patients with rheumatoid arthritis or connective tissue disease","volume":"2","author":"Yakova","year":"2005","journal-title":"Retrovirology"},{"issue":"8555","key":"10.1016\/j.micpath.2022.105622_bib132","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0140-6736(87)92431-7","article-title":"Can HTLV-1 lead to immunological disease?","volume":"2","author":"Vernant","year":"1987","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.micpath.2022.105622_bib133","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2169\/internalmedicine.32.261","article-title":"Mixed connective tissue disease and Sjogren's syndrome, accompanied by HTLV-I infection","volume":"32","author":"Matsumoto","year":"1993","journal-title":"Intern. Med."},{"issue":"1","key":"10.1016\/j.micpath.2022.105622_bib134","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0022-510X(98)00066-5","article-title":"HTLV-I-associated myelopathy associated with multi-organ inflammatory disease: a case report","volume":"157","author":"Furuya","year":"1998","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.micpath.2022.105622_bib135","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3201\/eid1001.020714","article-title":"Respiratory and urinary tract infections, arthritis, and asthma associated with HTLV-I and HTLV-II infection","volume":"10","author":"Murphy","year":"2004","journal-title":"Emerg. Infect. Dis."},{"issue":"1","key":"10.1016\/j.micpath.2022.105622_bib136","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s004670000458","article-title":"Human T-cell lymphotropic virus-1-associated renal disease in Jamaican children","volume":"16","author":"Miller","year":"2001","journal-title":"Pediatr. Nephrol."},{"issue":"11","key":"10.1016\/j.micpath.2022.105622_bib137","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1086\/508899","article-title":"Long-term variations in human T lymphotropic virus (HTLV)-I and HTLV-II proviral loads and association with clinical data","volume":"194","author":"Kwaan","year":"2006","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.micpath.2022.105622_bib138","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/infdis\/173.3.584","article-title":"Evaluation of morbidity among human T lymphotropic virus type 1 carriers in Miyazaki, Japan","volume":"173","author":"Stuver","year":"1996","journal-title":"J. Infect. Dis."},{"issue":"10","key":"10.1016\/j.micpath.2022.105622_bib139","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1002\/jmv.25532","article-title":"Higher human T-cell leukaemia virus type 1 (HTLV-1) proviral load is associated with end-stage kidney disease in Indigenous Australians: results of a case-control study in central Australia","volume":"91","author":"Talukder","year":"2019","journal-title":"J. Med. Virol."},{"issue":"1","key":"10.1016\/j.micpath.2022.105622_bib140","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF02775062","article-title":"Incidence of anti-HTLV-1 antibody in liver disease","volume":"27","author":"Nakano","year":"1992","journal-title":"Gastroenterol. Jpn."},{"issue":"9","key":"10.1016\/j.micpath.2022.105622_bib141","first-page":"1074","article-title":"[Six cases of HTLV-I associated bronchiolo-alveolar disorder (HABA)]","volume":"27","author":"Kimura","year":"1989","journal-title":"Nihon Kyobu Shikkan Gakkai Zasshi"},{"issue":"12","key":"10.1016\/j.micpath.2022.105622_bib142","first-page":"1055","article-title":"[A case of HTLV-1 associated bronchiolo-alveolar disorder showing progressive air trapping]","volume":"46","author":"Mikita","year":"2008","journal-title":"Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society"},{"issue":"23","key":"10.1016\/j.micpath.2022.105622_bib143","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.2169\/internalmedicine.54.4717","article-title":"Human T-cell lymphotropic virus type-1 (HTLV-1)-associated bronchioloalveolar disorder presenting with mosaic perfusion","volume":"54","author":"Yamakawa","year":"2015","journal-title":"Intern. Med."},{"issue":"4","key":"10.1016\/j.micpath.2022.105622_bib144","doi-asserted-by":"crossref","first-page":"479","DOI":"10.4269\/ajtmh.1994.50.479","article-title":"Type-specific immune response to human T cell lymphotropic virus (HTLV) type I and type II infections in Nigeria","volume":"50","author":"Olaleye","year":"1994","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"10","key":"10.1016\/j.micpath.2022.105622_bib145","first-page":"1066","article-title":"HTLV-1 infection is frequent among out-patients with pulmonary tuberculosis in northern Lima, Peru","volume":"11","author":"Verdonck","year":"2007","journal-title":"Int. J. Tubercul. Lung Dis. : Off. J. Int. Union Against Tubercul. Lung Dis."},{"key":"10.1016\/j.micpath.2022.105622_bib146","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.tube.2017.10.004","article-title":"Impaired TNF, IL-1beta, and IL-17 production and increased susceptibility to Mycobacterium tuberculosis infection in HTLV-1 infected individuals","volume":"108","author":"Carvalho","year":"2018","journal-title":"Tuberculosis"},{"key":"10.1016\/j.micpath.2022.105622_bib147","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1186\/s12879-016-1428-z","article-title":"Tuberculosis incidence in a cohort of individuals infected with human T-lymphotropic virus type 1 (HTLV-1) in Salvador, Brazil","volume":"16","author":"Grassi","year":"2016","journal-title":"BMC Infect. Dis."},{"issue":"7","key":"10.1016\/j.micpath.2022.105622_bib148","first-page":"309","article-title":"Detection of HTLV-1 gag related sequences in leucocyte DNA from patients with polyendocrinopathies (Basedow-Graves' disease and insulin-dependent diabetes)","volume":"312","author":"Lagaye","year":"1991","journal-title":"C. R. Acad. Sci. Ser. III Sci. Vie"},{"issue":"2","key":"10.1016\/j.micpath.2022.105622_bib149","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF00270582","article-title":"Graves' disease in HTLV-I carriers","volume":"73","author":"Kawai","year":"1995","journal-title":"J. Mol. Med. (Berl.)"},{"issue":"2","key":"10.1016\/j.micpath.2022.105622_bib150","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0925-5710(97)00595-1","article-title":"An HTLV-I carrier with Graves' disease followed by uveitis: isolation of HTLV-I from thyroid tissue","volume":"66","author":"Kubonishi","year":"1997","journal-title":"Int. J. Hematol."},{"issue":"2","key":"10.1016\/j.micpath.2022.105622_bib151","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00000441-200208000-00012","article-title":"Severe graves ophthalmopathy accompanied by HTLV-1-associated uveitis (HAU) and anti-neutrophil cytoplasmic antibody-related vasculitis: a case report and a review of the literature of HAU with Graves disease","volume":"324","author":"Sarui","year":"2002","journal-title":"Am. J. Med. Sci."},{"issue":"5","key":"10.1016\/j.micpath.2022.105622_bib152","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1136\/bjo.77.5.274","article-title":"Clinical features of HTLV-I associated uveitis","volume":"77","author":"Nakao","year":"1993","journal-title":"Br. J. Ophthalmol."},{"issue":"2","key":"10.1016\/j.micpath.2022.105622_bib153","first-page":"162","article-title":"A multicenter case-control study of HTLV-I associated uveitis. Study Group for HTLV-I Associated Ocular Diseases","volume":"38","author":"Ohba","year":"1994","journal-title":"Jpn. J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.micpath.2022.105622_bib154","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/bjo.78.3.163","article-title":"Human T lymphotropic virus type 1 uveitis after Graves' disease","volume":"78","author":"Yamaguchi","year":"1994","journal-title":"Br. J. Ophthalmol."},{"issue":"11","key":"10.1016\/j.micpath.2022.105622_bib155","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1136\/bjo.79.11.1018","article-title":"HTLV-I associated uveitis in central Japan","volume":"79","author":"Goto","year":"1995","journal-title":"Br. J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.micpath.2022.105622_bib156","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jcv.2011.07.016","article-title":"Keratoconjunctivitis sicca of human T cell lymphotropic virus type 1 (HTLV-1) infected individuals is associated with high levels of HTLV-1 proviral load","volume":"52","author":"Castro-Lima Vargens","year":"2011","journal-title":"J. Clin. Virol. : Off. Publ. Pan Am. Soc. Clin. Virol."},{"key":"10.1016\/j.micpath.2022.105622_bib157","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3389\/fmicb.2012.00270","article-title":"HTLV-1 uveitis","volume":"3","author":"Kamoi","year":"2012","journal-title":"Front. Microbiol."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401022002352?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401022002352?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:44:44Z","timestamp":1760111084000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401022002352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":157,"alternative-id":["S0882401022002352"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2022.105622","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HTLV, a multi organ oncovirus","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2022.105622","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105622"}}